Loading
MN
MicroPort NeuroScientific Corporation Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Zhang Jie, was filed 20 Apr 2026.
Insider Decl.
17
Thresholds
n/a
Buy Volume
€693,650
17 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleXie Zhiyong3 buys
Wang Yiqun Bruce2 buys
Sun Qingwei1 buy
Zhang Jie1 buy
Since the insiders bought
- -18.0%Entry HK$10.78 · Close at T+90 HK$8.84
- -28.0%Entry HK$11.18 · Close 21 Oct 2026 HK$8.06
- +7.5%Entry HK$10.20 · Close at T+365 HK$10.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,445 of 26,280 companies
66.5
score / 100
Value49
Quality84
FCF yld3.4%
Earn yld4.0%
EV/EBITDA15.8x
ROE11%
Gross mgn73%
Net mgn23%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$8.06
Analyst consensus
1 analystsHK$12.89Target HK$12.89(+60%)HK$12.89
Income statement
RevenueHK$790.5M
Gross profitHK$580.7M73% margin
EBITDAHK$290.7M37% margin
Net incomeHK$184.5M23.3% margin
Valuation
PER (trailing)23.0x
PER (forward)16.8x
P/Book2.2x
Beta-0.07
Balance sheet & cash
Market capHK$4.6B
Total debtHK$15.9M
Free Cash FlowHK$154.4M
Debt / Equity1%
Profitability & ownership
ROE10.5%
ROA9.2%
% insiders39.7%
% institutions1.2%
Last declaration on 20 April 2026
Declarations17 total
30,067 sharesShareXHKGHKEX:DA20260418E00005
Canonical exit: 29 Jun 2026 (T+90)
247,000 sharesShareXHKGHKEX:DA20260408E00422
Canonical exit: 30 Jun 2026 (T+90)
80,000 sharesShareXHKGHKEX:DA20250509E00280
Canonical exit: 4 Aug 2025 (T+90)
139,000 sharesShareXHKGHKEX:DA20250509E00246
Canonical exit: 4 Aug 2025 (T+90)
253,000 sharesShareXHKGHKEX:DA20250509E00268
Canonical exit: 4 Aug 2025 (T+90)
139,000 shares@ HK$9.58100.0% of flowShareXHKGHKEX:DA20250412E00002
Canonical exit: 7 Jul 2025 (T+90)
253,000 shares@ HK$9.5852.8% of flowShareXHKGHKEX:DA20250411E00385
Canonical exit: 7 Jul 2025 (T+90)
79,000 sharesShareXHKGHKEX:DA20241030E00242
Canonical exit: 12 Dec 2024 (T+90)
126,000 sharesShareXHKGHKEX:DA20241030E00232
Canonical exit: 12 Dec 2024 (T+90)
80,000 sharesShareXHKGHKEX:DA20240409E00002
Canonical exit: 26 Jun 2024 (T+90)
125,000 sharesShareXHKGHKEX:DA20240409E00005
Canonical exit: 26 Jun 2024 (T+90)
239,000 sharesShareXHKGHKEX:DA20240409E00003
Canonical exit: 26 Jun 2024 (T+90)
256,000 shares@ HK$8.3847.2% of flowShareXHKGHKEX:DA20240409E00004
Canonical exit: 26 Jun 2024 (T+90)
79,000 sharesShareXHKGHKEX:DA20230802E00345
Canonical exit: 26 Oct 2023 (T+90)
126,000 sharesShareXHKGHKEX:DA20230802E00344
Canonical exit: 26 Oct 2023 (T+90)
79,063 sharesShareXHKGHKEX:DA20230405E00255
Canonical exit: 28 Jun 2023 (T+90)
125,775 sharesShareXHKGHKEX:DA20230405E00247
Canonical exit: 28 Jun 2023 (T+90)
17 of 17 declarations
About MicroPort NeuroScientific Corporation
MicroPort NeuroScientific Corporation, a healthcare company listed in Hong Kong and valued at HKD 4.6 billion, has only purchases: 17 filings, all by directors, of which only 3 carry an amount, EUR 693,650 in all (median EUR 253,518). Xie Zhiyong bought EUR 284,065 on April 8, 2025 and EUR 253,518 on March 28, 2024; Wang Yiqun Bruce, EUR 156,067 on April 8, 2025.
Xie Zhiyong signs 8 filings, Wang Yiqun Bruce 6, Sun Qingwei 2 and Zhang Jie 1. Between April 8, 2025 and May 6, 2025, 3 filers bought. No sale appears in the record, which covers 4 filers and annual volume of 4 filings in 2023, 6 in 2024, 5 in 2025 and 2 in 2026.
Read moreShow less
The 2 filings of 2026 are the only ones of the last twelve months, and both are purchases. All four filers carry the title of director. The median publication delay is 6 days. Insiders hold 39.7% of the capital.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
